Trial Profile
Proof of Concept Study: Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia; Restless legs syndrome
- Focus Proof of concept; Therapeutic Use
- 23 Mar 2018 New trial record